本頁面由Tiger Trade Technology Pte. Ltd.提供服務

1藥網

7.10
+0.15002.16%
成交量:5,782.00
成交額:4.04萬
市值:6,153.88萬
市盈率:-6.26
高:7.10
開:6.93
低:6.88
收:6.95
52周最高:11.35
52周最低:2.48
股本:866.74萬
流通股本:350.51萬
量比:0.98
換手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-1.1341
每股收益(LYR):-1.0324
淨資產收益率:-10.86%
總資產收益率:-0.21%
市淨率:-0.62
市盈率(LYR):-6.88

資料載入中...

2025/08/29

SEC問詢函

Form CORRESP - Correspondence
2025/08/29

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

SEC問詢函

Form CORRESP - Correspondence
2025/08/06

SEC問詢函

Form CORRESP - Correspondence
2025/04/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/14

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

SEC問詢函

Form CORRESP - Correspondence
2023/07/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/31

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/27

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/23

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/09

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/19

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]